Overview
Hiroki Mano practices practicing medicine in Toyama, Japan.
Mr. Mano is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Rickets, Malnutrition, X-Linked Hypophosphatemia, and Hypophosphatemia.
He is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroki Mano
Is Hiroki Mano a top-rated expert for Rickets?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroki Mano is classified as an Advanced expert for Rickets, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroki Mano participate in research or clinical trials?
Yes. Hiroki Mano has published 25 articles and abstracts on conditions like Rickets. You can view a list of Hiroki Mano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- MalnutritionMr. Mano isAdvanced. Learn about Malnutrition.
- RicketsMr. Mano isAdvanced. Learn about Rickets.
- Experienced
- HypophosphatemiaMr. Mano isExperienced. Learn about Hypophosphatemia.
- X-Linked HypophosphatemiaMr. Mano isExperienced. Learn about X-Linked Hypophosphatemia.